The Evolution of Covered Stents for Hemodialysis Access

The WRAPSODY® Cell-Impermeable Endoprosthesis (CIE) addresses the shortcomings of previous covered stents, offering a durable, optimized option for treating stenosis in AVFs and AVGs.

By Bart Dolmatch, MD, FSIR

The Early Days of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE)

A case highlighting the efficacy and durability of the WRAPSODY CIE and an overview of how my practice utilizes it.

By Andrew Wigham, BSc(Hons), MBBS, MRCS, FRCR

WRAPSODY® Clinical Trial Program

A discussion of the WAVE trial’s methods and insights gained, impactful results from the 6-month AVF cohort, and the unique features of the WRAPSODY Cell-Impermeable Endoprosthesis (CIE).

With moderator Dr. Dheeraj Rajan and panelists Drs. Mahmood Razavi and Robert Jones

WRAPSODY® WAVE Study Core Lab Findings and Health Economics

A summary of my center’s experience in the WAVE pivotal trial, what makes the WRAPSODY Cell-Impermeable Endoprosthesis (CIE) unique, and the importance of access circuit primary patency in payment models and costs of arteriovenous access management.

By Saravanan Balamuthusamy, MD, FASN, FASDIN

Real-World Experience With the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE): Results From a Multicenter Registry in Brazil

A summary of clinical outcomes from the Vascular and Endovascular Access Society (SAVE)* patient registry in Brazil, implications for practice, and notable features of the WRAPSODY CIE that are changing the reality of dialysis management.

By Leonardo Harduin, MD, MSc, PhD